Home / Patients Family / Academy / Digital Academy

Digital Academy

Representatives from various biotech and pharmaceutical companies around the world discuss early stage therapies currently under development. Featuring Dr. Friedrich Metzger, PhD, Head of Discover in Rare Diseases at Roche; Dr. Takako Moriguchi, PhD, Senior Scientist at Genzyme; and Michael French, Chief Executive Officer at Marina Biotech.

Dr. Laurence Mignon, PhD, Director of Clinical Development at Isis Pharmaceuticals, gives an update on the status of the DMPKrx Phase I/II trial.

Dr. Sharon Hesterlee, PhD, Chief Science Officer at MDF, discusses the Foundation's multi-year vision to accelerate DM research.

MDF Fellows report on the current status of their research findings. Featuring: Dr. Ranjan Batra, PhD, University of California San Diego; Dr. Viachaslau Bernat, PhD, Scripps Research Institute Florida; Dr. Melissa Hinman, PhD, University of Oregon; and Dr. Ravi Kanth Rao Saini, PhD, Scripps Research Institute La Jolla.

In this webinar, Dr. Bruce Wentworth of Genzyme and Jeanne Dekdebrun and Elizabeth Luebbe of the University of Rochester discuss an overview of the clinical trials process.


© Myotonic Dystrophy Foundation. All rights reserved.